ICVTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2008;7:50-53. doi:10.1510/icvts.2007.160846
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
József Furák
Imre Troján
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Furák, J.
Right arrow Articles by Lázár, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furák, J.
Right arrow Articles by Lázár, G.
Related Collections
Right arrow Lung - basic science
Right arrow Lung - cancer

Institutional report - Thoracic general

Lung cancer as a second primary malignant tumor: prognostic values after surgical resection{star}

József Furáka,*, Imre Trojána, Tamás Szökea, Antal Wolfárda, Ernest Nagya, István Némethb, László Tiszlaviczb and György Lázára

a Department of Surgery, University of Szeged, Pécsi u. 4. H-6720, Szeged, Hungary
b Department of Pathology, University of Szeged, Szeged, Hungary

*Corresponding author. Tel.: +36 30 9955815; fax: +36 62 545 701.

E-mail address: jfurak{at}hotmail.com (J. Furák).

Prognostic values of lung cancers as second primary malignant tumors (LC-as-SPTs) developed after a different type of first primary malignant tumor were analyzed. Forty-three patients underwent surgery for first primary malignant tumors and later for LC-as-SPTs. The most frequent first primary tumors were: 14 laryngo-pharyngeals; 7 lungs; and 5 colons. Only metachronous cases were included in our study, and the disease-free intervals (DFI) between the first and second primary tumors were divided into two groups: shorter than 36 months (DFI<36), and longer than 36 months (DFI>36). The survival was calculated from the time of surgery for LC-as-SPT. The 5-year overall survival rate was 38%. By univariate analysis, the 5-year survival was significantly lower in cases with DFI<36 months (25%) than in cases with DFI>36 months (43%) (P=0.045), and in male (27%) than in female (62%) (P=0.032), and in N1 (31%) and N2 (0%) cases than in N0 (49%) cases (P=0.001). Using multivariate analysis with the previous factors, only the lymph node metastasis (P=0.001) had a significant impact on survival. The survival after LC-as-SPTs was shorter than after first primary lung cancer cases, and lymph node involvement had a significant impact on the postoperative survival based on uni- and multivariate analysis.

Key Words: Lung cancer; Second primary malignant tumor; Disease-free interval







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-thoracic Surgery